Abstract

Background:Infertility is one of the common health issues around the world. The prevalence of male factor infertility among infertile couples is approximately 30%-35%, of which genetic factors account for 15%. The family-based whole-exome sequencing (WES) approach can accurately detect novel variants. However, selecting an appropriate sample for data generation using WES has proven to be challenging in familial male infertility studies. The aim of this study was to identify types of pathogenic male infertility in cases of familial asthenozoospermia.

Case: Two families with multiple cases were recruited for the purpose of WES. The study population included two affected cases in pedigree I and three affected cases in pedigree II. Two different variant callers (SAMtools and GATK) with a single-sample calling strategy (SSCS) and a multiple-sample calling strategy (MSCS), were applied to identify variant sites.

Conclusion: In this study, we represented the results for variant prioritization of WES data without sequencing fertile siblings in the same pedigree by applying two different pipelines (homozygosity and linkage-based strategy). Using the aforementioned strategies, we prioritized annotated variants and generated a logical shortlist of private variants for each pedigree.

Details

Title
Strategies for whole-exome sequencing analysis in a case series study of familial male infertility
Author
Askari, Masomeh  VIAFID ORCID Logo  ; Dor Mohammad Kordi Tamandani  VIAFID ORCID Logo  ; Almadani, Navid  VIAFID ORCID Logo  ; Totonchi, Mehdi  VIAFID ORCID Logo 
Pages
375-384
Section
Original Article
Publication year
2020
Publication date
May 2020
Publisher
Yazd Shahid Sadoughi University of Medical Sciences, Research and Clinical Center for Infertility
ISSN
24764108
e-ISSN
24763772
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2682801953
Copyright
© 2020. This work is published under https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.